Capstone Partners advised CP Medical, a wholly owned subsidiary of Theragenics Corporation and a leading manufacturer of medical sutures, on its sale to Riverpoint Medical. Terms of the deal were not disclosed.
Founded in 1990 and headquartered in Norcross, Georgia, CP Medical is a leading manufacturer in the suture space with a specialization in surgical applications and wound closure products for the animal healthcare market. CP Medical products are primarily sold to the veterinary market with limited distribution in the dental and dermatology segments. The company manufactures private label suture products for Covetrus, the largest distributor of veterinary products in the U.S. Learn more about CP Medical here.
The Capstone team brought deep industry knowledge to our process and their senior level was engaged throughout. Their entire team was extremely responsive from start to finish and, most importantly, understood our business’ unique attributes. Their marketing efforts generated significant interest which ultimately led to identifying the ideal partner and a successful outcome.
“The management team at CP Medical and their parent company, Theragenics, were fantastic to work with,” said Tom Elliott, Managing Director at Capstone and the bank’s lead advisor on the transaction. Elliott added, “Our client’s high level of professionalism allowed us to orchestrate a productive sale process that created a mutually beneficial result for the buyers and sellers. Divesting of CP was the right move for Theragenics, and combining with Riverpoint was the right move for CP.”
Riverpoint Medical, a portfolio company of Arlington Capital Partners, is a leading developer, designer, and manufacturer of medical devices with a focus on regenerative technologies and advanced surgical fiber. Riverpoint Medical offers a variety of products for the surgical and healthcare markets including implants, high strength fiber solutions, and proprietary surgical coatings. Learn more about Riverpoint Medical here.
Gordon Auduong, a Principal at Arlington Capital Partners, commented, “The addition of CP Medical aligns seamlessly with Riverpoint’s growth strategy and allows the company to further its commitment to delivering high-quality surgical solutions. We look forward to leveraging CP Medical’s established relationships to deliver the same level of innovation, excellence, and service that Riverpoint is known with its customers.”
The expert investment banking professionals on Capstone Partners’ Pet Care Team work with leading middle market companies operating in the Pet Care market to advise with their strategic decision-making in order to maximize financial outcomes at every stage of the business lifecycle. Our firm has developed a full suite of corporate finance solutions, including M&A advisory, debt advisory, financial advisory, and equity capital financing to help privately owned businesses and private equity firms address any need, ranging from growth and financial or operational advisement to an ultimate exit transaction. To learn more about this transaction, or about the benefits of starting a relationship with our Pet Care Banking Team, contact us here.
